We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 4,781 results
  1. Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization

    Background and Purpose

    Waning immunity and the surge of SARS-CoV-2 variants are responsible for breakthrough infections, i.e., infections in fully...

    Giulia Lamacchia, Alessio Mazzoni, ... Francesco Annunziato in Journal of Clinical Immunology
    Article Open access 09 July 2022
  2. IL-38, a potential therapeutic agent for lupus, inhibits lupus progression

    Background

    Previous studies reported that IL-38 was abnormally expressed in patients with systemic lupus erythematosus (SLE). However, the involvement...

    Wang-Dong Xu, Lin-Chong Su, ... An-Fang Huang in Inflammation Research
    Article 01 July 2022
  3. SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study

    It is well established that neurological and non-neurological autoimmune disorders can be triggered by viral infections. It remains unclear whether...

    Cecilia Zivelonghi, Alessandro Dinoto, ... Sara Mariotto in Immunologic Research
    Article Open access 12 May 2023
  4. Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity

    Background

    This study aimed to explore a correlation between plasma angiotensin II/(1–7) (Ang II/Ang-(1–7)) ratio, anti-ACE2 autoantibodies level and...

    Sana Khajeh Pour, Craig Scoville, ... Ali Aghazadeh-Habashi in Inflammopharmacology
    Article 26 May 2022
  5. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis

    Lupus nephritis (LN) is a severe and common manifestation of systemic lupus erythematosus (SLE) that is frequently identified with a poor prognosis....

    Limei Zhao, Shuqin Tang, ... **aoshuang Zhou in Molecular Medicine
    Article Open access 25 June 2024
  6. Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19

    Several genetic and immunological risk factors for severe COVID-19 have been identified, with monogenic conditions relating to 13 genes of type I...

    L. E. Covill, A. Sendel, ... Y. T. Bryceson in Journal of Clinical Immunology
    Article Open access 17 January 2024
  7. Adaptive Immunity and the Clinical Definition of Autoantibodies

    Detection of autoantibodies in the patient’s serum is a key diagnostic tool in autoimmune liver diseases, provided that the clinician is familiar...
    Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani in Liver Immunology
    Chapter 2020
  8. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

    Background

    Comprehensive data on the cerebrospinal fluid (CSF) profile in patients with COVID-19 and neurological involvement from large-scale...

    Sven Jarius, Florence Pache, ... Brigitte Wildemann in Journal of Neuroinflammation
    Article Open access 20 January 2022
  9. Lupus progression deteriorates oogenesis quality in MRL/lpr mice

    Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the activation of the immune response against self antigens. Numerous...

    Stefka Delimitreva, Gabriela Boneva, ... Andrey Tchorbanov in Immunologic Research
    Article 21 May 2024
  10. Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis

    Acetylcholine receptor (AChR) myasthenia gravis (MG) is a chronic autoimmune disease characterized by muscle weakness. The AChR + autoantibodies are...

    José A. Villegas, Jérôme Van Wassenhove, ... Nadine Dragin in Journal of Neuroinflammation
    Article Open access 13 January 2023
  11. Human serum-derived α-synuclein auto-antibodies mediate NMDA receptor-dependent degeneration of CNS neurons

    Background

    Presence of autoantibodies against α-synuclein (α-syn AAb) in serum of the general population has been widely reported. That such...

    Pretty Garg, Franziska Würtz, ... Mathias Bähr in Journal of Neuroinflammation
    Article Open access 28 February 2024
  12. Detection of T Follicular Helper Cells and T Follicular Regulatory Cells in Experimental Sjögren’s Syndrome

    With the compiling studies on the autoimmune pathogenesis in the develo** of Sjögren’s syndrome, the functional importance of T follicular helper...
    Sulan Yu, Meiling Wu, ... **ang Lin in T-Follicular Helper Cells
    Protocol 2022
  13. Cytokine expression profiles in white blood cells of patients with small fiber neuropathy

    Background

    The role of cytokines in the pathophysiology, diagnosis, and prognosis of small fiber neuropathy (SFN) is incompletely understood. We...

    Luisa Kreß, Nadine Egenolf, ... Nurcan Üçeyler in BMC Neuroscience
    Article Open access 05 January 2023
  14. What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms

    Background

    Coronavirus disease 19 (COVID-19) is the disease caused by SARS-CoV-2, a highly infectious member of the coronavirus family, which emerged...

    Sawsan Aboul-Fotouh, Ahmed Nageh Mahmoud, ... Sahar M. Abdelraouf in Virology Journal
    Article Open access 24 October 2023
  15. The therapeutic age of the neonatal Fc receptor

    IgGs are essential soluble components of the adaptive immune response that evolved to protect the body from infection. Compared with other...

    Michal Pyzik, Lisa K. Kozicky, ... Richard S. Blumberg in Nature Reviews Immunology
    Article 01 February 2023
  16. Transfer of patient’s peripheral blood mononuclear cells (PBMCs) disrupts blood–brain barrier and induces anti-NMDAR encephalitis: a study of novel humanized PBMC mouse model

    Background

    Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neuropsychiatric disease. Brain access of anti-NMDAR...

    Yaqing Shu, Fuhua Peng, ... Wei Qiu in Journal of Neuroinflammation
    Article Open access 13 July 2023
  17. Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes

    Objective and design

    Systemic-Inflammatory-Autoimmune-Diseases (SIAD) is increasingly considered in Myelodysplastic-Syndromes (MDS). In this line, we...

    Antonio Cristiano, Riccardo Belardi, ... Marzia Nuccetelli in Inflammation Research
    Article Open access 28 July 2023
  18. Novel Mutation in the Moesin (MSN) Gene Leads to Immunodeficiency with Epstein–Barr Virus (EBV) Infection and Dermatomyositis-Like Symptoms

    Purpose

    Moesin (MSN) deficiency is a recently reported combined immunodeficiency, and few cases have been reported to date. We describe a Chinese...

    Bijun Sun, Luyao Liu, ... **qiao Sun in Journal of Clinical Immunology
    Article 26 June 2024
  19. Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency

    Purpose

    Inborn errors of IFN-γ immunity underlie Mendelian susceptibility to mycobacterial disease (MSMD). Twenty-two genes with products involved in...

    Jérémie Rosain, Ayca Kiykim, ... Jacinta Bustamante in Journal of Clinical Immunology
    Article Open access 16 February 2024
  20. Immunogenetics of Lupus Erythematosus

    Lupus erythematosus (LE) is a heterogeneous disease with a wide range of manifestations ranging from localized lesions in cutaneous lupusCutaneous...
    Begüm Ünlü, Ümit Türsen, ... Fateme Rajabi in The Immunogenetics of Dermatologic Diseases
    Chapter 2022
Did you find what you were looking for? Share feedback.